Staphylococcus aureus antigens (S. aureus antigens)

Staphylococcus aureus antigens encompass a diverse array of molecules expressed by the bacterium to facilitate colonization, tissue invasion, and evasion of the host immune system. These include surface-anchored proteins like Clumping factor A (ClfA) and Iron-regulated surface determinant B (IsdB), as well as secreted toxins such as alpha-hemolysin (Hla) and various leukocidins [1][2]. These antigens play critical roles in pathogenesis; for instance, MSCRAMMs (Microbial Surface Components Recognizing Adhesive Matrix Molecules) mediate attachment to host extracellular matrix proteins, while toxins disrupt host cell membranes to cause cell death and tissue damage [3]. In the context of drug development, these antigens have been the primary targets for both active immunotherapies (vaccines) and passive immunotherapies (monoclonal antibodies) [4]. Despite their clear role in disease, targeting S. aureus antigens has proven exceptionally challenging, with many high-profile vaccine candidates failing in Phase III clinical trials [5]. This difficulty is attributed to the bacterium's redundant virulence factors and its ability to shield itself from the immune system using proteins like Protein A (SpA), which binds the Fc region of antibodies to prevent proper opsonization [6].

Other names

Staphylococcal antigensS. aureus surface proteinsMicrobial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs)Staphylococcal toxinsCapsular polysaccharides

Neutralization of bacterial toxins, inhibition of bacterial adhesion to host tissues, promotion of opsonophagocytosis, and interruption of nutrient acquisition.